Prostate Cancer Outcomes: International Registry to Improve Outcomes in Men with Advanced Prostate Cancer (IRONMAN)
The Prostate Cancer Outcomes International Registry (IRONMAN) is designed to create an international, population-based registry of 5,000 men with advanced prostate cancer and to describe variations in patient management, experiences, and outcomes in this population. The IRONMAN Registry will recruit 5,000 patients internationally with advanced prostate cancer; including men with newly diagnosed metastatic hormone sensitive prostate cancer and men with M0 and M1 castrate-resistant prostate cancer. Standardised patient-reported outcomes will be collected every 3 months for up to 5 years. Collection of baseline demographics/prior therapies and blood collection will follow informed consent, with follow up data collected for overall survival, skeletal events, hospitalisations, incidence of cardiovascular disease, cancer and acute and chronic diseases, bone scan and imaging.
This information will:
- Inform best treatment practices for patients with advanced disease
- Describe the clinical and molecular subtypes of advanced disease
- Define unmet needs for further study particularly emphasising patient experiences
Investigators
| Ian Vela | Princess Alexandra Hospital |
| Jeffrey Goh | Royal Brisbane & Women's Hospital |
| Katharine Cuff | Princess Alexandra Hospital |
| Colleen Nelson | APCRC-Q and QUT |
| David Pryor | Princess Alexandra Hospital |
Duration
Funding
| Movember Foundation |
